What were some of your most satisfying successes of the past year, and why? Advising on the J&J spin-off, which was transformative for our client. Many large pharma players are spinning off their consumer health businesses, and we've established ourselves as go-to advisors in this space. In addition to advising J&J, we've advised GSK and Merck on their spin-offs.